Jazz Pharmaceuticals plc
JAZZ
$229.63
$0.440.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 44.06% | -19.08% | 134.99% | -676.72% | -148.40% |
| Total Depreciation and Amortization | 1.25% | 0.52% | 2.43% | 5.59% | -2.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -202.97% | 161.28% | -108.94% | 1,277.95% | -41.42% |
| Change in Net Operating Assets | 83.37% | -155.59% | 140.00% | -213.66% | 460.06% |
| Cash from Operations | 12.60% | -23.62% | 434.15% | -79.33% | 7.83% |
| Capital Expenditure | -17.76% | -10.24% | -17.03% | 6.71% | -4.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 137.23% | -22.70% | -235.92% | 248.29% | 13.83% |
| Cash from Investing | 133.08% | -13.53% | 48.86% | -279.30% | 12.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.65% | 0.00% | 0.00% | 98.98% | -9,678.06% |
| Issuance of Common Stock | -61.38% | 11,521.56% | -93.02% | -8.72% | 25.05% |
| Repurchase of Common Stock | -5,090.38% | 47.64% | 97.00% | -89.39% | -1,577.90% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -204.06% | 796.65% | 91.30% | 84.69% | -9,730.82% |
| Foreign Exchange rate Adjustments | -1,312.12% | -83.74% | -95.61% | 172.00% | 174.27% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 587.24% | -51.66% | 120.26% | -21.97% | -382.96% |